Skip to main content

Animations

MJFF Publications

5991 - 6000 of 8808 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2023
  • 2024
  • 2020
  • 2020
  • 2024
  • 2021
  • 2017
  • 2019
  • Summary Details
    RESTRICTED
    Title: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26659
    Citation Count: 130
  • Summary Details
    OPEN
    Title: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awad162
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variant
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae073
    Citation Count: 21
  • Summary Details
    OPEN
    Title: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1122
    Citation Count: 14
  • Summary Details
    OPEN
    Title: A novel method for calculating beta band burst durations in Parkinson’s disease using a physiological baseline
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2020.108811
    Citation Count: 30
  • Summary Details
    OPEN
    Title: A simulated annealing algorithm for randomizing weighted networks
    Journal Name: Nature Computational Science
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43588-024-00735-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28533
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9
    Citation Count: 123
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.